G

Guangdong Marubi Biotechnology Co Ltd
SSE:603983

Watchlist Manager
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Watchlist
Price: 33.56 CNY -2.27%
Market Cap: 13.5B CNY
Have any thoughts about
Guangdong Marubi Biotechnology Co Ltd?
Write Note

Net Margin
Guangdong Marubi Biotechnology Co Ltd

12.3%
Current
12%
Average
3.3%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
324.4m
/
Revenue
2.6B

Net Margin Across Competitors

Country CN
Market Cap 13.8B CNY
Net Margin
12%
Country FR
Market Cap 181.7B EUR
Net Margin
15%
Country UK
Market Cap 114.1B GBP
Net Margin
11%
Country IN
Market Cap 5.5T INR
Net Margin
17%
Country UK
Market Cap 34.9B GBP
Net Margin
11%
Country DE
Market Cap 27.8B EUR
Net Margin
8%
Country US
Market Cap 27B USD
Net Margin
1%
Country JP
Market Cap 3T JPY
Net Margin
5%
Country IN
Market Cap 1.1T INR
Net Margin
-3%
Country IN
Market Cap 903.7B INR
Net Margin
14%
Country US
Market Cap 9.9B USD
Net Margin
12%
No Stocks Found

Guangdong Marubi Biotechnology Co Ltd
Glance View

Market Cap
13.5B CNY
Industry
Consumer products

Guangdong Marubi Biotechnology Co Ltd stands as a compelling narrative of innovation and heritage in the realm of beauty and skincare. Established in 2002, the company has carved a niche in China’s competitive cosmetics industry by blending advanced biotechnology with traditional skincare practices. This fusion forms the backbone of Marubi’s product portfolio, which spans an array of skincare solutions including anti-aging serums, hydrating masks, and rejuvenating creams. The company’s strength lies in its robust research and development framework, where scientific rigor meets the potential of natural ingredients, leading to the formulation of effective skincare products. By fostering partnerships with renowned research institutions, Marubi ensures that its offerings are not only well-aligned with consumer expectations but also backed by solid scientific evidence. In the financial landscape, Marubi’s operational model is keenly focused on understanding consumer trends and leveraging digital marketing strategies to solidify its market position. A significant portion of the company’s revenues is generated through e-commerce platforms, which tap into China’s rapidly growing online retail market. Emphasizing brand loyalty and customer engagement, Marubi has utilized social media and collaborations with influencers to promote its products and extend its reach beyond traditional retail channels. Moreover, the company has established a keen presence in offline sales, ensuring its brand stands out in both bustling urban centers and emerging local markets. Through this strategic synergy between online and offline sales avenues, Guangdong Marubi Biotechnology Co Ltd thrives as a modern skincare powerhouse, creating value continuously in an ever-evolving market landscape.

Intrinsic Value
31.9 CNY
Overvaluation 5%
Intrinsic Value
Price
G

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
324.4m
/
Revenue
2.6B
What is the Net Margin of Guangdong Marubi Biotechnology Co Ltd?

Based on Guangdong Marubi Biotechnology Co Ltd's most recent financial statements, the company has Net Margin of 12.3%.